Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 253 (117th)

Cannabidiol and Marihuana Research Expansion Act

openUnited States· United States Congress· EN

Introduced

4 February 2021

Last action

28 March 2022 · Floor

Status

Held at the desk.

Sponsors

Sen. Feinstein, Dianne [D-CA], Sen. Grassley, Chuck [R-IA], Sen. Schatz, Brian [D-HI], Sen. Durbin, Richard J. [D-IL], Sen. Klobuchar, Amy [D-MN], Sen. Tillis, Thomas [R-NC], Sen. Kaine, Tim [D-VA], Sen. Ernst, Joni [R-IA], Sen. Tester, Jon [D-MT], Sen. Murkowski, Lisa [R-AK], Sen. Cramer, Kevin [R-ND]

Subjects

Education

Source updated

10 August 2026

Education

Official sourceDownload fileView documentsShare

Summary

Cannabidiol and Marihuana Research Expansion Act This bill establishes a new, separate registration process to facilitate research on marijuana. Specifically, the bill directs the Drug Enforcement Administration (DEA) to follow specified procedures to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research. The bill allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the bill directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative. Finally, the bill includes various other provisions, including provisions that require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes; prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research; allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well as the impact on adolescent brains and on the ability to operate a motor vehicle.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 4 February 2021

    Introduced

    Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S477-478)

    Source: IntroReferral

  2. 4 February 2021

    Introduced

    Introduced in Senate

    Source: IntroReferral

  3. 24 March 2022

    Discharge

    Senate Committee on the Judiciary discharged by Unanimous Consent.

    Source: Discharge

  4. 24 March 2022

    Committee

    Senate Committee on the Judiciary discharged by Unanimous Consent.

    Source: Committee

  5. 24 March 2022

    Floor

    Measure laid before Senate by unanimous consent. (consideration: CR S1784)

    Source: Floor

  6. 24 March 2022

    Passed

    Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S1781-1783)

    Source: Floor

  7. 28 March 2022

    Floor

    Held at the desk.

    Source: Floor

  8. 28 March 2022

    Floor

    Received in the House.

    Source: Floor

  9. 28 March 2022

    Floor

    Message on Senate action sent to the House.

    Source: Floor

Votes

No vote records are attached yet.

Versions

Documents

6 official files

Engrossed in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in Senate (text)

    Engrossed in Senate · EN · 24 March 2022

    ViewDownloadOpen at official source

  • Engrossed in Senate (PDF)

    Engrossed in Senate · EN · 24 March 2022

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Passed Senate

    summary · EN · 24 March 2022

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 4 February 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 4 February 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 4 February 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.